Thus, Aux-COPII-CAM and Aux-EGFR will be promising biomarkers for colorectal cancer diagnosis, while targeting JAK/STAT and EGFR signaling will be an effective treatment of colorectal cancer. The gene discussed is EGFR; the disease is colorectal cancer.